Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Jason is a general assignment reporter, with particular focus on genetic medicine ...
The number of people receiving treatment at the National Institutes of Health Clinical Center — the renowned research hospital that cares for patients with rare or life-threatening diseases — has ...
One of the most successful research enterprises funded by the NIH, the Clinical Research Center (CRC) program, is dying, its highly productive life cut short with virtually no discussion in the ...
In President Donald Trump's second term, nearly 700 NIH grants totalling $1.8 billion were terminated. The only two centers spared by the cuts were the NIH Clinical Center and the National Center for ...
Jack Leslie (SFS ’76), professor of the practice in the Georgetown University School of Health (SOH), was named chair of the National Institutes of Health (NIH) Clinical Center Research Hospital Board ...
Patient volumes at the National Institutes of Health Clinical Center have fallen sharply in recent months, coinciding with staffing disruptions at HHS and the cancellation of research grants under the ...
Chimeric antigen receptor T-cell therapies have been approved by the FDA for two indications thus far, with a third for multiple myeloma expected sometime next year. James N. Kochenderfer, MD, a ...
Dr. John Gallin, longtime director of the National Institutes of Health's research hospital, has been moved to a new role months after a report sharply criticized the Clinical Center's leadership. NIH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results